Publikationen von Michael W. Sereda
Alle Typen
Zeitschriftenartikel (50)
1.
Zeitschriftenartikel
16, S. 616 - 640 (2024)
Targeting PI3K/Akt/mTOR signaling in rodent models of PMP22 gene-dosage diseases. Embo Molecular Medicine 2.
Zeitschriftenartikel
35 (12), S. 2136 - 2152.e9 (2023)
Adipo-glial signaling mediates metabolic adaptation in peripheral nerve regeneration. Cell Metabolism 3.
Zeitschriftenartikel
24, S. 47 - 60 (2021)
Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nature Neuroscience 4.
Zeitschriftenartikel
98 (10), S. 1933 - 1952 (2020)
Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot–Marie–Tooth disease type 1A (CMT1A) rats. Journal of Neuroscience Research 5.
Zeitschriftenartikel
27 (8), S. 1390 - 1396 (2020)
Pregnancy outcome in Charcot–Marie–Tooth disease: results of the CMT‐NET cohort study in Germany. European Journal of Neurology 6.
Zeitschriftenartikel
9, e51406 (2020)
Proteome profile of peripheral myelin in healthy mice and in a neuropathy model. eLife 7.
Zeitschriftenartikel
39 (28), S. 5606 - 5626 (2019)
Myelinating glia-specific deletion of Fbxo7 in mice triggers axonal degeneration in the central nervous system together with peripheral neuropathy. The Journal of Neuroscience 8.
Zeitschriftenartikel
10, 1467 (2019)
NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies. Nature Communications 9.
Zeitschriftenartikel
14 (1), e0209752 (2019)
Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A). PLoS One 10.
Zeitschriftenartikel
9, 3025 (2018)
Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy. Nature Communications 11.
Zeitschriftenartikel
88 (11), S. 941 - 952 (2017)
Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A. Journal of Neurology, Neurosurgery & Psychiatry 12.
Zeitschriftenartikel
6, e23332 (2017)
Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy. eLife 13.
Zeitschriftenartikel
8, 17 (2017)
Rho kinase inhibition with Fasudil in SOD1(G93A) mouse model of Amyotrophic Lateral Sclerosis - symptomatic treatment potential after diesease onset. Frontiers in Pharmacology 14.
Zeitschriftenartikel
95 (11), S. 145 - 157 (2016)
Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. Neurobiology of Disease 15.
Zeitschriftenartikel
19 (8), S. 1050 - 1059 (2016)
Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair. Nature Neuroscience 16.
Zeitschriftenartikel
18 (5), S. 443 - 451 (2016)
The role of combined SNV and CNV burden in patients with distal symmetric polyneuropathy. Genetics in Medicine 17.
Zeitschriftenartikel
64 (1), S. 155 - 174 (2016)
Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking. Glia 18.
Zeitschriftenartikel
2 (8), S. 787 - 796 (2015)
Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher disease. Annals of Clinical and Translational Neurology 19.
Zeitschriftenartikel
4, 53 (2015)
A brief review of recent Charcot-Marie-Tooth research and priorities. Faculty of 1000 Research 20.
Zeitschriftenartikel
9 (1), 201 (2014)
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet Journal of Rare Diseases